|
|
||||||||
From the Departments of Neurology (Drs. Lamperti, Naini, Hirano, and DiMauro) and Pediatrics (Drs. De Vivo and Chiriboga), Columbia University College of Physicians and Surgeons, New York, NY; the Pediatric Hospital "Bambino Gesù" (Drs. Bertini and Valeriani), Rome; the Institute of Neurology (Dr. Servidei), Catholic University, Rome, Italy; the Division of Neurology (Dr. Lynch), Childrens Hospital of Philadelphia, PA; the Division of Neurology, Department of Pediatrics (Dr. Banwell), Hospital for Sick Children, Toronto, Ontario, Canada; the Department of Neurology (Dr. Berg), Strong Memorial Hospital, Rochester, NY; the Office of Pediatric Neurology (Dr. Dubrovsky), Hollywood, FL, and the Department of Neurology (Drs. Angelini and Pegoraro), University of Padova, Italy.
Address correspondence and reprint requests to Dr. Salvatore DiMauro, 4-420 College of Physicians & Surgeons, 630 West 168th Street, New York, NY; e-mail, sd12{at}columbia.edu
The authors measured coenzyme Q10 (CoQ10) concentration in muscle biopsies from 135 patients with genetically undefined cerebellar ataxia. Thirteen patients with childhood-onset ataxia and cerebellar atrophy had markedly decreased levels of CoQ10. Associated symptoms included seizures, developmental delay, mental retardation, and pyramidal signs. These findings confirm the existence of an ataxic presentation of CoQ10 deficiency, which may be responsive to CoQ10 supplementation.
This article has been cited by other articles:
![]() |
C. M. Quinzii, L. C. Lopez, J. Von-Moltke, A. Naini, S. Krishna, M. Schuelke, L. Salviati, P. Navas, S. DiMauro, and M. Hirano Respiratory chain dysfunction and oxidative stress correlate with severity of primary CoQ10 deficiency FASEB J, June 1, 2008; 22(6): 1874 - 1885. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Diomedi-Camassei, S. Di Giandomenico, F. M. Santorelli, G. Caridi, F. Piemonte, G. Montini, G. M. Ghiggeri, L. Murer, L. Barisoni, A. Pastore, et al. COQ2 Nephropathy: A Newly Described Inherited Mitochondriopathy with Primary Renal Involvement J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2773 - 2780. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Gempel, H. Topaloglu, B. Talim, P. Schneiderat, B. G. H. Schoser, V. H. Hans, B. Palmafy, G. Kale, A. Tokatli, C. Quinzii, et al. The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene Brain, August 1, 2007; 130(8): 2037 - 2044. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Lopez-Martin, L. Salviati, E. Trevisson, G. Montini, S. DiMauro, C. Quinzii, M. Hirano, A. Rodriguez-Hernandez, M. D. Cordero, J. A. Sanchez-Alcazar, et al. Missense mutation of the COQ2 gene causes defects of bioenergetics and de novo pyrimidine synthesis Hum. Mol. Genet., May 1, 2007; 16(9): 1091 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Horvath, P. Schneiderat, B.G.H. Schoser, K. Gempel, E. Neuen-Jacob, H. Ploger, J. Muller-Hocker, D. E. Pongratz, A. Naini, S. DiMauro, et al. Coenzyme Q10 deficiency and isolated myopathy Neurology, January 24, 2006; 66(2): 253 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lamperti, A. B. Naini, V. Lucchini, A. Prelle, N. Bresolin, M. Moggio, M. Sciacco, P. Kaufmann, and S. DiMauro Muscle Coenzyme Q10 Level in Statin-Related Myopathy Arch Neurol, November 1, 2005; 62(11): 1709 - 1712. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Salviati, S. Sacconi, L. Murer, G. Zacchello, L. Franceschini, A. M. Laverda, G. Basso, C. Quinzii, C. Angelini, M. Hirano, et al. Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: A CoQ10-responsive condition Neurology, August 23, 2005; 65(4): 606 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Scaglia, L.-J. C. Wong, G. D. Vladutiu, and J. V. Hunter Predominant Cerebellar Volume Loss as a Neuroradiologic Feature of Pediatric Respiratory Chain Defects AJNR Am. J. Neuroradiol., August 1, 2005; 26(7): 1675 - 1680. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Quinzii, A. G. Kattah, A. Naini, H. O. Akman, V. K. Mootha, S. DiMauro, and M. Hirano Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation Neurology, February 8, 2005; 64(3): 539 - 541. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Lalani, G. D. Vladutiu, K. Plunkett, T. E. Lotze, A. M. Adesina, and F. Scaglia Isolated Mitochondrial Myopathy Associated With Muscle Coenzyme Q10 Deficiency Arch Neurol, February 1, 2005; 62(2): 317 - 320. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Aure, J. F. Benoist, H. O. de Baulny, N. B. Romero, O. Rigal, and A. Lombes Progression despite replacement of a myopathic form of coenzyme Q10 defect Neurology, August 24, 2004; 63(4): 727 - 729. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Rundek, A. Naini, R. Sacco, K. Coates, and S. DiMauro Atorvastatin Decreases the Coenzyme Q10 Level in the Blood of Patients at Risk for Cardiovascular Disease and Stroke Arch Neurol, June 1, 2004; 61(6): 889 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gironi, C. Lamperti, R. Nemni, M. Moggio, G. Comi, F. R. Guerini, P. Ferrante, N. Canal, A. Naini, N. Bresolin, et al. Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency Neurology, March 9, 2004; 62(5): 818 - 820. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |